Why the study?
There is limited research examining the efficacy of double sequential external defibrillation in clinical practice, and previous research is confounded by the use of advanced cardiac life support medications.
Does double sequential external defibrillation (DSED) improve resuscitation in a patient with refractory out-of-hospital cardiac arrest?
Does double sequential external defibrillation (DSED) improve resuscitation in a patient with refractory out-of-hospital cardiac arrest?
Double sequential external defibrillation (DSED) can be successfully employed by basic life support providers for refractory out-of-hospital cardiac arrest without advanced life support medications.
Answers are grounded in this paper and cite their sources.
Supports DSED feasibility in refractory VF without medications; hypothesis-generating and requires prospective trials before practice change.
Double sequential external defibrillation (DSED) is a novel treatment option for cardiac arrest patients in refractory ventricular fibrillation (VF). There is limited research, however, examining the efficacy of this treatment in clinical practice. Previous research is further confounded by the use of other treatments such as advanced cardiac life support medications. We present the case of the successful use of DSED for refractory out-of-hospital cardiac arrest without the use of advanced life support care.
No takes yet. Share an insight, caveat, or question.
Laird et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: